NEFL and myeloid sarcoma: Given that ALS patients exhibited significantly elevated NfL levels compared to MS patients, we assume that the autoantibodies targeting the identified autoantigens observed in MS group are unlikely a result of non-specific axonal damage and neuroinflammation.